Standout Papers
Citation Impact
Citing Papers
The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease
2009
Implantable Cardioverter-Defibrillators in Tetralogy of Fallot
2008
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
2013
Single molecules of the bacterial actin MreB undergo directed treadmilling motion in Caulobacter crescentus
2006 StandoutNobel
Accelerated telomere shortening in response to life stress
2004 StandoutNobel
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients With New York Heart Association Class IV Heart Failure
2006
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure
2009
Cardiomyopathy, familial dilated
2006
Withdrawing Implantable Defibrillator Shock Therapy in Terminally Ill Patients
2006
CKD: Common, Harmful, and Treatable—World Kidney Day 2007
2007
Survival in octogenarians receiving implantable defibrillators
2006
The prevention of heart failure in minority communities and discrepancies in health care delivery systems
2004
Relation of Loop Diuretic Dose to Mortality in Advanced Heart Failure
2006
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy
2002
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more
2006
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
1999
Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients
2002
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations
2003
Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator
2010
Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America
2008
Categorization of humans in biomedical research: genes, race and disease.
2002
Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure
2006
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications
2015
Results of a Multicenter Retrospective Implantable Cardioverter-Defibrillator Registry of Pediatric and Congenital Heart Disease Patients
2008
Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol
2005
Cardiovascular drug class specificity: β-blockers
2004
Experiences of Driving and Driving Restrictions in Recipients With an Implantable Cardioverter Defibrillator-The Patient Perspective
2010
Age‐Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study
2008
ICD Implantation and Arrhythmia‐Free Survival in Patients with Depressed LV Function Following Surgery for Valvular Heart Disease
2008
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure
2001
Use of Nonantiarrhythmic Drugs for Prevention of Sudden Cardiac Death
2003
Wound repair and regeneration
2008 StandoutNature
The Myth of the “Vulnerable Plaque”
2015
HFSA 2006 Comprehensive Heart Failure Practice Guideline: Introduction and Table of Contents
2006
Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy
2007
Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation
2013
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
1998
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Prevention of heart failure
2002
Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section
2012
The Managed Ventricular Pacing™ Versus VVI 40 Pacing (MVP) Trial: Clinical Background, Rationale, Design, and Implementation
2006
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays
2011
Dilated cardiomyopathy
2010
Silent cerebral white matter lesions in middle-aged essential hypertensive patients
2002
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
Noninvasive Risk Assessment Early After a Myocardial Infarction
2007
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation
2011
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
2009
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study
2010
Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?
2006
Randomized controlled crossover study of the effect on proteinuria and blood pressure of adding an angiotensin II receptor antagonist to an angiotensin converting enzyme inhibitor in normotensive patients with chronic renal disease and proteinuria
2002
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
2010
Usefulness of Elevations in Serum Choline and Free F2-Isoprostane to Predict 30-Day Cardiovascular Outcomes in Patients With Acute Coronary Syndrome
2009
Implantable Cardioverter Defibrillators in Patients with Valvular Cardiomyopathy
2012
Chronic kidney disease
2011 Standout
Clinical outcomes in heart failure: report from a community hospital-based registry
1999
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
2014
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: A meta-analysis of >35,000 patients
2014
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates
2014
HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials
2014
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials
2009
Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
2008
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy
2012
Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
2013
Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome
2008 Standout
Effect of Cardiac and Noncardiac Conditions on Survival After Defibrillator Implantation
2007
How to use high-sensitivity cardiac troponins in acute cardiac care
2012
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
2004
Review of the Registry’s First Year, Data Collected, and Future Plans
2007
Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction
2004
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials
2007
New-onset diabetes and antihypertensive drugs
2005
Successes and failures of current treatment of heart failure
1998
Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial
2011
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease
2010
Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure
2001 Standout
The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
2012
Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment
2006
Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance
2005
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
2011
Clinical experience with a novel subcutaneous implantable defibrillator system in a single center
2011
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
The Role of the Wearable Cardioverter Defibrillator in Clinical Practice
2014
Conceptual Model of CKD: Applications and Implications
2009
Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population
2010
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the Centers for Disease Control and Prevention
2009
Moderate Alcohol Consumption and Risk of Heart Failure Among Older Persons
2001
Implantable Cardioverter-Defibrillator Shocks
2013
Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome
2007
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Aortic pulse wave velocity index and mortality in end-stage renal disease
2003
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
2000
The Cost Effectiveness of Implantable Cardioverter-Defibrillators
2006
Aggregate National Experience With the Wearable Cardioverter-Defibrillator
2010
Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator
2010
The Entirely Subcutaneous Implantable Cardioverter-Defibrillator
2012
Cardiac Dysfunction Occurs in the HIV-1 Transgenic Mouse Treated with Zidovudine
2000
Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups
2002
Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure
2008
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
2000
One-Hour Rule-out and Rule-in of Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin T
2012
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
2008
Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management
2014
Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial
2013
Effect of continuous positive airway pressure on ventricular ectopy in heart failure patients with obstructive sleep apnoea
2005
Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000
2005
Randomized Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Diabetic Patients
2010
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
The mosaic that is our genome
2003 StandoutNatureNobel
Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
Usefulness of Sleep-Disordered Breathing to Predict Occurrence of Appropriate and Inappropriate Implantable-Cardioverter Defibrillator Therapy in Patients With Implantable Cardioverter-Defibrillator for Primary Prevention of Sudden Cardiac Death
2013
Implantable Cardioverter Defibrillator Therapy in Patients with Prior Coronary Revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD‐HeFT)
2008
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
2013
Third Universal Definition of Myocardial Infarction
2012 Standout
Sudden Death Due to Cardiac Arrhythmias
2001
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Shock Anxiety among Implantable Cardioverter Defibrillator Recipients with Recent Tachyarrhythmia
2012
Regulation of cytoskeletal dynamics by actin-monomer-binding proteins
2004
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy
2003
The pathophysiology of acute heart failure—Is it all about fluid accumulation?
2007
Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly
2012
Comparison of Benefit and Mortality of Implantable Cardioverter–Defibrillator Therapy in Patients Aged ≥75 Years Versus Those <75 Years
2011
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
1999 Standout
Time Dependence of Defibrillator Benefit After Coronary Revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II
2006
Surgery for ventricular tachycardia in patients undergoing surgical ventricular restoration: The Karolinska approach
2007
Introduction of High-sensitivity Troponin Assays: Impact on Myocardial Infarction Incidence and Prognosis
2012
Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)
2005
Cost-Effectiveness of Implantable Cardioverter–Defibrillators
2005
Pediatric ICD utilization in the United States from 1997 to 2006
2010
Ultrafiltration Versus Usual Care for Hospitalized Patients With Heart Failure
2005
Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
2005
Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
2011
Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure
2006
Wearable defibrillator use in heart failure (WIF): results of a prospective registry
2012
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Expansion of Heart Failure Device Therapy Into a Rural Indigent Population in Louisiana: Potential Economic and Health Policy Implications
2006
Frequency of Cardiac Death in Children With Idiopathic Dilated Cardiomyopathy
2009
Addendum to “Personal and Public Safety Issues Related to Arrhythmias that May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/Scientific Statement from the American Heart Association and the North American Society of Pacing and Electrophysiology”
2007
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients
2005
Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure
2007
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status
2003
Complications Associated With Implantable Cardioverter-Defibrillator Replacement in Response to Device Advisories
2006
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Defibrillator Implantation Early after Myocardial Infarction
2009
Biomarkers in Heart Failure
2008 Standout
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
2008
Management of atrial fibrillation in patients with heart failure
2006
Sudden Cardiac Death Risk Stratification in Patients With Nonischemic Dilated Cardiomyopathy
2014
Association Between Blood Pressure Level and the Risk of Myocardial Infarction, Stroke, and Total Mortality
2001
Cardiac Sympathetic Imaging With mIBG in Heart Failure
2010
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
2004 Standout
Practical Applications of Intravenous Diuretic Therapy in Decompensated Heart Failure
2006
Pulse pressure—a review of mechanisms and clinical relevance
2001
A Pilot Study Examining the Performance of Polynomial‐Modeled Ventricular Shock Electrograms for Rhythm Discrimination in Implantable Devices
2006
Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure
2005
Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease
2007
Cardiovascular Outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial
2006
Determinants of High-Sensitivity Troponin T Among Patients with a Noncardiac Cause of Chest Pain
2012
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
2007
Race, Quality of Care, and Outcomes of Elderly Patients Hospitalized With Heart Failure
2003
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Ventricular Tachyarrhythmias and Mortality in Patients With an Implantable Cardioverter Defibrillator
2013
Racial differences in response to therapy for heart failure: Analysis of the vasodilator-heart failure trials
1999
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
2013
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
2006
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator
2015
Clinical trials update from the American Heart Association meeting: ACORN‐CSD, primary care trial of chronic disease management, PEACE, CREATE, SHIELD, A‐HeFT, GEMINI, vitamin E meta‐analysis, ESCAPE, CARP, and SCD‐HeFT cost‐effectiveness study
2004
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008
2009
Long-Term Outcomes of Dilated Cardiomyopathy Diagnosed During Childhood
2013
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)
2007
Sudden Cardiac Death in Adult Congenital Heart Disease
2012
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
2006
HIF-1α is required for development of the sympathetic nervous system
2019 StandoutNobel
Chronic Heart Failure in the United States
1998
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
2005
Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women
2004
Periprocedural Myocardial Infarction
2010
Implantable Cardioverter Defibrillator Therapy
2000
Arterial Stiffness and Cardiovascular Events
2010 Standout
Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator
2001
Meta-analysis: Age and Effectiveness of Prophylactic Implantable Cardioverter-Defibrillators
2010
Effect of Candesartan on Cause-Specific Mortality in Heart Failure Patients
2004
Vasopressin V 2 -Receptor Blockade With Tolvaptan in Patients With Chronic Heart Failure
2003
Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure
2006
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease
2011
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold
2006
Systolic and Diastolic Blood Pressure, Pulse Pressure, and Mean Arterial Pressure as Predictors of Cardiovascular Disease Risk in Men
2000
Genetic Structure of Human Populations
2002 StandoutScience
Recursive partitioning for heterogeneous causal effects
2016 StandoutNobel
Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
2006
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Improving Survival Rates of Patients With Idiopathic Dilated Cardiomyopathy in Tuscany Over 3 Decades
2013
Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients
2005
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Pacemaker and ICD Generator Malfunctions
2006
Incidence and Predictors of Sudden Cardiac Arrest in Adults With Congenital Heart Defects Repaired Before Adult Life
2012
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Stroke in patients with heart failure and reduced left ventricular ejection fraction
2000
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population
2005
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
2009
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients
2001 Standout
Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients
2005
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)
2011
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
2009
Implantable Cardioverter Defibrillators in Primary and Secondary Prevention
2003
Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias
2007
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias
2002
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
2003 Standout
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
2001
High-Sensitivity Cardiac Troponin T for Early Prediction of Evolving Non–ST-Segment Elevation Myocardial Infarction in Patients with Suspected Acute Coronary Syndrome and Negative Troponin Results on Admission
2010
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Unstable Angina
2013
Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction
2013
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Quality of Life and Psychological Status of Patients With Implantable Cardioverter Defibrillators
2006
Contemporary Pacemaker and Defibrillator Device Therapy
2007
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
The Year in Heart Failure 2005
2006
Epidemiology and Genetics of Sudden Cardiac Death
2012
Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates
2001
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Cross-Sectional Correlates of Increased Aortic Stiffness in the Community
2007
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
2006
Mechanisms of Diabetic Complications
2013 Standout
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
2007
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Seattle Heart Failure Model
2006
Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction
2008
Blood Pressure Lowering in Type 2 Diabetes
2015
Telomere Length Inversely Correlates With Pulse Pressure and Is Highly Familial
2000
Chronic Kidney Disease
2007
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Arterial Stiffness and Risk of Coronary Heart Disease and Stroke
2006
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
2014
Stiffness of Carotid Artery Wall Material and Blood Pressure in Humans
2000
[The Rotterdam study].
2011
Long-Term Arrhythmia-Free Survival in Patients With Severe Left Ventricular Dysfunction and No Inducible Ventricular Tachycardia After Myocardial Infarction
2014
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
2011
Aortic Stiffness Is an Independent Predictor of Fatal Stroke in Essential Hypertension
2003
High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation
2013
Repeated echocardiography after first ever ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention – is it necessary?
2014
Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic Hypertension
2002
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
2011
High-Sensitivity Cardiac Troponin I Measurement for Risk Stratification in a Stable High-Risk Population
2011
Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril
2006
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003 Standout
Single Versus Combined Blood Pressure Components and Risk for Cardiovascular Disease
2009
Left Ventricular Structure and Function in Children Infected With Human Immunodeficiency Virus
1998
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Alcohol Consumption and Risk for Congestive Heart Failure in the Framingham Heart Study
2002
Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure
2007
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
The Efficacy of Implantable Cardioverter-Defibrillators in Heart Transplant Recipients
2009
Works of Michaël Domanski being referenced
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
2007
Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study
2001
Frequency of Aspirin Resistance in a Community Hospital
2006
Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction
2000
Detection of High-Risk Atherosclerotic Plaque
2012
A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease
2009
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial
2003
Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Prognostic factors for atherosclerosis progression in saphenous vein grafts
2000
Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus
1995
Coupling of Folding and Binding of Thymosin β4 upon Interaction with Monomeric Actin Monitored by Nuclear Magnetic Resonance
2004
Failure of benefit and early hazard of bucindolol for Class IV heart failure
2003
Racial Differences in the Outcome of Left Ventricular Dysfunction
1999
Rationale, Design, and Methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE)
2007
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial
2008
Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
1999
Diuretic Use, Progressive Heart Failure, and Death in Patients in the DIG Study
2006
Pulse Pressure and Cardiovascular Disease–Related Mortality
2002
Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
2003
Effect of Antithrombotic Therapy on Risk of Sudden Coronary Death in Patients With Congestive Heart Failure
1997
Ejection Fraction and Risk of Thromboembolic Events in Patients With Systolic Dysfunction and Sinus Rhythm: Evidence for Gender Differences in the Studies of Left Ventricular Dysfunction Trials
1997
Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction
2001
Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery
2011
Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk
2020
Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction
1999
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction
1999
A comparative analysis of the results from 4 trials of β-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS
2003
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
2005 Standout
Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction
1999
Long-Term Trandolapril Treatment Is Associated With Reduced Aortic Stiffness
2007
Isolated Systolic Hypertension
1999
Clinical factors that influence response to treatment strategies in atrial fibrillation: The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study
2005
Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction
1999
Cardiovascular Risk Assessment Using Pulse Pressure in the First National Health and Nutrition Examination Survey (NHANES I)
2001
Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease
2007
Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery Disease
2007
Aggressive Cholesterol Lowering Delays Saphenous Vein Graft Atherosclerosis in Women, the Elderly, and Patients With Associated Risk Factors
1999
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial
2006
Treatment of Sudden Cardiac Death
1997
Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery
2012